Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Time comparison of bowel programs in spinal cord injury

Official title: Time Comparison of Bisacodyl Suppository, Enemeez and Peristeen on Bowel Programs in Patients With Diagnosis of Spinal Cord Injury and Neurogenic Bowel

Run by Casa Colina Hospital and Centers for Healthcare · NCT07817199 · Data updated 2026-11-12

This study tests which of three bowel-management tools (a suppository, a mini enema, or a transanal irrigation device) helps people with spinal cord injury complete their bowel program the quickest.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorCasa Colina Hospital and Centers for Healthcare
Academic / other
Locations1 site (Pomona, California)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJuly 1, 2027
Study endsAugust 1, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07817199 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with spinal cord injury and reflexic neurogenic bowel requiring a bowel program who are admitted to the inpatient rehab unit at Casa Colina Hospital.

Probably not a fit

Patients whose bowel program timing is not noticeably shortened or whose condition worsens with a particular tool may experience no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare three bowel-management options—suppository, Enemeez mini enema, and Peristeen transanal irrigation—to see which one lets patients finish their bowel program fastest. The study uses three sequential cohorts, each month assigning a different intervention to participants starting their bowel program. Outcomes include time spent on the bowel program, episodes of incontinence or constipation, and user satisfaction. The trial aims to inform clinical practice to reduce caregiver burden and improve patient experience in neurogenic bowel management after spinal cord injury. Conducted at Casa Colina Hospital, the study will enroll adults with reflexic neurogenic bowel admitted to the inpatient rehab unit.

Why it matters

Potential benefit: If a tool is shown to save time and improve comfort, patients may experience a smoother, quicker bowel routine and staff may have more time for other care activities.

How similar studies have gone: Similar approaches have explored device- or drug-specific bowel management options, with mixed but informative results guiding device selection in neurogenic bowel care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* admission to acute rehab inpatient unit
* diagnosis of spinal cord injury
* reflexive type neurogenic bowel requiring bowel program with suppository and digital stimulation

Exclusion Criteria:

* anal or rectal stenosis
* active inflammatory bowel disease
* acute diverticulitis
* colorectal cancer
* ischemic colitis
* rectal surgery within the last 3 months
* endoscopic polypectomy within the last 4 weeks
* areflexic bowel
* severe autonomic dysreflexia

Where it's running

  • Casa Colina Hospital and Centers for Healthcare
    Pomona, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.